Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New agents for the treatment of acute myeloid leukemia.

Best practice & research. Clinical haematology - 1 Jan 2006

Tallman Martin S

Abstract excerpt

The heterogeneity of acute myeloid leukemia (AML) has been established by many new insights into the diagnosis, pathogenesis, clinical manifestations, treatment, and prognosis of patients with AML. Morphology remains the foundation for the diagnosis. However, additional diagnostic studies, including immunophenotyping, cytogenetic evaluation, and molecular genetic studies, are necessary to develop treatments...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Alkylating
Share to Clinical Trials, Phase III as Topic
Share to Cytogenetics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Leukemic

Share to Immunophenotyping

Share to Immunotherapy

Share to Purines

Share to Remission Induction

Source

Identifiers

PMID: 16516128
DOI: 10.1016/j.beha.2005.11.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New agents for the treatment of acute myeloid leukemia.PMID 16516128Read ↗

New agents for acute myeloid leukemia: is it time for targeted therapies?Semantic proximity Read ↗

New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agents.Semantic proximity Read ↗

Emerging therapies for acute myeloid leukemia: translating biology into the clinic.Semantic proximity Read ↗

Novel therapeutic strategies for AML in 2012.Semantic proximity Read ↗

An Overview of Targeted Therapies in Acute Myeloid LeukemiaSemantic proximity Read ↗

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting ChallengesSemantic proximity Read ↗

Recent advances in the understanding and treatment of acute myeloid leukemiaSemantic proximity Read ↗

Update on Small Molecule Targeted Therapies for Acute Myeloid Leukemia.Semantic proximity Read ↗

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid LeukemiaSemantic proximity Read ↗

Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia.Semantic proximity Read ↗

Acute myeloid leukemia: advancing clinical trials and promising therapeutics.Semantic proximity Read ↗

Identifying effective drug combinations for patients with acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.